東華大學圖書館 |

Peritoneal tumors and metastases = surgical, intraperitoneal and systemic therapy /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Peritoneal tumors and metastases/ edited by Beate Rau ... [et al.].
其他題名:	surgical, intraperitoneal and systemic therapy /
其他作者:	Rau, Beate.
出版者:	Cham :Springer International Publishing : : 2021.,
面頁冊數:	xix, 407 p. :ill., digital ;24 cm.
內容註:	I Basics -- 1 Anatomy and pathology of the peritoneum -- 2 Pharmacovigilance of topical chemotherapy in the peritoneum -- II Diagnostics and natural course -- 3 Imaging diagnostics of tumors of the peritoneum -- 4 Role of laparoscopy in the diagnosis of tumors of the peritoneum -- 5 Scoring systems for CRS and HIPEC -- 6 Natural course of peritoneal carcinomatosis -- III Therapy options of systemic therapy -- 7 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the upper GI tract -- 8 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the lower GI tract including appendiceal carcinoma -- IV Treatment options for surgical cytoreduction -- 9 Procedures of parietal and visceral peritonectomy in the upper abdomen -- 10 Technique of visceral and parietal peritonectomy in the lower abdomen -- 11 Procedures of parietal and visceral peritonectomy interenterically -- 12 Cytoreduction - preparation devices -- V therapy options of intraperitoneal therapy and experimental approaches -- 13 Application of IPC, HIPEC and PIPAC -- 14 Cytokine-induced senescence: an experimental therapy for peritoneal tumors -- 15 Mechanism of action and experimental and clinical data on regional hyperthermia -- 16 HIPEC in childhood -- VI Potentially curative approach -- 17 Importance of intraperitoneal chemotherapy as a prophylaxis after curative resection of a gastrointestinal carcinoma -- 18 Indication of CRS and HIPEC in Pseudomyxoma peritonei -- 19 Significance of CRS and HIPEC in mesothelioma -- 20 Indication of CRS and HIPEC in peritoneal metastatic gastric carcinoma -- 21 Indication of CRS and HIPEC in peritoneal metastases of colorectal carcinomas -- 22 Indication of CRS and HIPEC in peritoneal metastases of ovarian cancer -- 23 Indication of CRS and HIPEC in peritoneal metastases of NET and small intestinal carcinomas -- 24 Indication of CRS and HIPEC in peritoneal metastases of pancreatic carcinomas -- 25 Indications of CRS and HIPEC in Incidentally Detected Peritoneal Carcinomatosis -- VII VII Palliative treatment attempt of advanced peritoneal metastasis -- 26 Importance of systemic chemotherapy in advanced peritoneal metastasis -- 27 Importance of PIPAC in advanced peritoneal metastasis -- VIII Complications in the Palliative Chemotherapy of Peritoneal Cancer -- 28 Complications in the Palliative Chemotherapy of Peritoneal Cancer -- 29 Cytoreductive surgery for complications of peritoneal carcinomatosis -- 30 IPEC, HIPEC, Bidirectional Chemotherapy and Immunotherapy in Aggressive Peritoneal Metastasis -- IX Perioperative treatment and prophylaxis of treatment related complications -- 31 Preoperative Management: Risk Assessment, Conditioning, Nutritional Aspects, Special Preparation, Including Bowel -- 32 Safety Considerations for Intraoperative Use of Cytostatic Agents -- 33 Preventing Complications of Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy -- 34 Nutritional Concepts in Patients with Peritoneal Tumors -- 35 Perioperative management -- X Quality of life -- 36 Quality of life at CRS and HIPEC -- 37 PIPAC Therapy and Quality of Life -- XI Recurrent diesease -- 38 Follow-Up to Prevent Recurrence of Peritoneal Malignancies -- 39 Localization of Localization of Peritoneal Tumor Recurrence -- 40 Treatment Options for Peritoneal Tumor Recurrence -- XII Environmental Aspects -- 41 Importance of Psycho-Oncology for Tumors of the Peritoneum -- 42 Nursing Aspects of Peritoneal Surface Malignancy -- XIII Guidelines and centres -- 43 Guideline preparation and center development for the treatment of peritoneal tumors in Germany -- 44 Guideline preparation and center development for the treatment of peritoneal tumors in Switzerland -- Service part -- 45 Checklists for the treatment of tumors of the peritoneum. Framework SOP -- Index.
Contained By:	Springer Nature eBook
標題:	Peritoneum - Cancer. -
電子資源:	https://doi.org/10.1007/978-3-030-62640-2
ISBN:	9783030626402

Peritoneal tumors and metastases = surgical, intraperitoneal and systemic therapy /
Peritoneale Tumoren und Metastasen.English

Peritoneal tumors and metastasessurgical, intraperitoneal and systemic therapy /[electronic resource] :edited by Beate Rau ... [et al.]. - Cham :Springer International Publishing :2021. - xix, 407 p. :ill., digital ;24 cm.

I Basics -- 1 Anatomy and pathology of the peritoneum -- 2 Pharmacovigilance of topical chemotherapy in the peritoneum -- II Diagnostics and natural course -- 3 Imaging diagnostics of tumors of the peritoneum -- 4 Role of laparoscopy in the diagnosis of tumors of the peritoneum -- 5 Scoring systems for CRS and HIPEC -- 6 Natural course of peritoneal carcinomatosis -- III Therapy options of systemic therapy -- 7 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the upper GI tract -- 8 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the lower GI tract including appendiceal carcinoma -- IV Treatment options for surgical cytoreduction -- 9 Procedures of parietal and visceral peritonectomy in the upper abdomen -- 10 Technique of visceral and parietal peritonectomy in the lower abdomen -- 11 Procedures of parietal and visceral peritonectomy interenterically -- 12 Cytoreduction - preparation devices -- V therapy options of intraperitoneal therapy and experimental approaches -- 13 Application of IPC, HIPEC and PIPAC -- 14 Cytokine-induced senescence: an experimental therapy for peritoneal tumors -- 15 Mechanism of action and experimental and clinical data on regional hyperthermia -- 16 HIPEC in childhood -- VI Potentially curative approach -- 17 Importance of intraperitoneal chemotherapy as a prophylaxis after curative resection of a gastrointestinal carcinoma -- 18 Indication of CRS and HIPEC in Pseudomyxoma peritonei -- 19 Significance of CRS and HIPEC in mesothelioma -- 20 Indication of CRS and HIPEC in peritoneal metastatic gastric carcinoma -- 21 Indication of CRS and HIPEC in peritoneal metastases of colorectal carcinomas -- 22 Indication of CRS and HIPEC in peritoneal metastases of ovarian cancer -- 23 Indication of CRS and HIPEC in peritoneal metastases of NET and small intestinal carcinomas -- 24 Indication of CRS and HIPEC in peritoneal metastases of pancreatic carcinomas -- 25 Indications of CRS and HIPEC in Incidentally Detected Peritoneal Carcinomatosis -- VII VII Palliative treatment attempt of advanced peritoneal metastasis -- 26 Importance of systemic chemotherapy in advanced peritoneal metastasis -- 27 Importance of PIPAC in advanced peritoneal metastasis -- VIII Complications in the Palliative Chemotherapy of Peritoneal Cancer -- 28 Complications in the Palliative Chemotherapy of Peritoneal Cancer -- 29 Cytoreductive surgery for complications of peritoneal carcinomatosis -- 30 IPEC, HIPEC, Bidirectional Chemotherapy and Immunotherapy in Aggressive Peritoneal Metastasis -- IX Perioperative treatment and prophylaxis of treatment related complications -- 31 Preoperative Management: Risk Assessment, Conditioning, Nutritional Aspects, Special Preparation, Including Bowel -- 32 Safety Considerations for Intraoperative Use of Cytostatic Agents -- 33 Preventing Complications of Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy -- 34 Nutritional Concepts in Patients with Peritoneal Tumors -- 35 Perioperative management -- X Quality of life -- 36 Quality of life at CRS and HIPEC -- 37 PIPAC Therapy and Quality of Life -- XI Recurrent diesease -- 38 Follow-Up to Prevent Recurrence of Peritoneal Malignancies -- 39 Localization of Localization of Peritoneal Tumor Recurrence -- 40 Treatment Options for Peritoneal Tumor Recurrence -- XII Environmental Aspects -- 41 Importance of Psycho-Oncology for Tumors of the Peritoneum -- 42 Nursing Aspects of Peritoneal Surface Malignancy -- XIII Guidelines and centres -- 43 Guideline preparation and center development for the treatment of peritoneal tumors in Germany -- 44 Guideline preparation and center development for the treatment of peritoneal tumors in Switzerland -- Service part -- 45 Checklists for the treatment of tumors of the peritoneum. Framework SOP -- Index.

This book provides surgeons and oncologists with a well-founded and detailed overview of the available treatment options for peritoneal malignancy and differential selection of the appropriate forms of therapy. Systemic chemotherapy options are also considered, as are surgical cytoreduction (CRS) and all forms of intraperitoneal chemotherapy (IPC) especially hyperthermic IPC (HIPEC), and immunotherapy, including specific procedures such as PIPAC. Subsequent chapters address perioperative care, complications and recurrences, as well as psycho-oncological, palliative medical and nursing care. The process of parietal and visceral peritonectomy in the large and small intestine is additionally illustrated by three video clips accessible online. Covering a broad range of aspects, including peritoneal metastasis and intraperitoneal chemotherapy, the book offers a valuable tool for surgeons, oncologists and anesthesiologists alike.

ISBN: 9783030626402

Standard No.: 10.1007/978-3-030-62640-2doiSubjects--Topical Terms:

2157988
Peritoneum
--Cancer.

LC Class. No.: RC280.P38 / P47 2021

Dewey Class. No.: 616.99495

National Library of Medicine Call No.: WI 575

Peritoneal tumors and metastases = surgical, intraperitoneal and systemic therapy /
LDR:05821nmm a2200337 a 4500 001 2240882
003 DE-He213
005 20210513205024.0
006 m d
007 cr nn 008maaau
008 211111s2021 sz s 0 eng d
020 $a 9783030626402 $q (electronic bk.)
020 $a 9783030626396 $q (paper)
024 7 $a 10.1007/978-3-030-62640-2 $2 doi
035 $a 978-3-030-62640-2
040 $a GP $c GP
041 1 $a eng $h ger
050 4 $a RC280.P38 $b P47 2021
060 4 $a WI 575
072 7 $a MN $2 bicssc
072 7 $a MED085000 $2 bisacsh
072 7 $a MN $2 thema
082 0 4 $a 616.99495 $2 23
090 $a RC280.P38 $b P446 2021
130 0 $a Peritoneale Tumoren und Metastasen. $l English $3 3496218
245 1 0 $a Peritoneal tumors and metastases $h [electronic resource] : $b surgical, intraperitoneal and systemic therapy / $c edited by Beate Rau ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xix, 407 p. : $b ill., digital ; $c 24 cm.
505 0 $a I Basics -- 1 Anatomy and pathology of the peritoneum -- 2 Pharmacovigilance of topical chemotherapy in the peritoneum -- II Diagnostics and natural course -- 3 Imaging diagnostics of tumors of the peritoneum -- 4 Role of laparoscopy in the diagnosis of tumors of the peritoneum -- 5 Scoring systems for CRS and HIPEC -- 6 Natural course of peritoneal carcinomatosis -- III Therapy options of systemic therapy -- 7 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the upper GI tract -- 8 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the lower GI tract including appendiceal carcinoma -- IV Treatment options for surgical cytoreduction -- 9 Procedures of parietal and visceral peritonectomy in the upper abdomen -- 10 Technique of visceral and parietal peritonectomy in the lower abdomen -- 11 Procedures of parietal and visceral peritonectomy interenterically -- 12 Cytoreduction - preparation devices -- V therapy options of intraperitoneal therapy and experimental approaches -- 13 Application of IPC, HIPEC and PIPAC -- 14 Cytokine-induced senescence: an experimental therapy for peritoneal tumors -- 15 Mechanism of action and experimental and clinical data on regional hyperthermia -- 16 HIPEC in childhood -- VI Potentially curative approach -- 17 Importance of intraperitoneal chemotherapy as a prophylaxis after curative resection of a gastrointestinal carcinoma -- 18 Indication of CRS and HIPEC in Pseudomyxoma peritonei -- 19 Significance of CRS and HIPEC in mesothelioma -- 20 Indication of CRS and HIPEC in peritoneal metastatic gastric carcinoma -- 21 Indication of CRS and HIPEC in peritoneal metastases of colorectal carcinomas -- 22 Indication of CRS and HIPEC in peritoneal metastases of ovarian cancer -- 23 Indication of CRS and HIPEC in peritoneal metastases of NET and small intestinal carcinomas -- 24 Indication of CRS and HIPEC in peritoneal metastases of pancreatic carcinomas -- 25 Indications of CRS and HIPEC in Incidentally Detected Peritoneal Carcinomatosis -- VII VII Palliative treatment attempt of advanced peritoneal metastasis -- 26 Importance of systemic chemotherapy in advanced peritoneal metastasis -- 27 Importance of PIPAC in advanced peritoneal metastasis -- VIII Complications in the Palliative Chemotherapy of Peritoneal Cancer -- 28 Complications in the Palliative Chemotherapy of Peritoneal Cancer -- 29 Cytoreductive surgery for complications of peritoneal carcinomatosis -- 30 IPEC, HIPEC, Bidirectional Chemotherapy and Immunotherapy in Aggressive Peritoneal Metastasis -- IX Perioperative treatment and prophylaxis of treatment related complications -- 31 Preoperative Management: Risk Assessment, Conditioning, Nutritional Aspects, Special Preparation, Including Bowel -- 32 Safety Considerations for Intraoperative Use of Cytostatic Agents -- 33 Preventing Complications of Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy -- 34 Nutritional Concepts in Patients with Peritoneal Tumors -- 35 Perioperative management -- X Quality of life -- 36 Quality of life at CRS and HIPEC -- 37 PIPAC Therapy and Quality of Life -- XI Recurrent diesease -- 38 Follow-Up to Prevent Recurrence of Peritoneal Malignancies -- 39 Localization of Localization of Peritoneal Tumor Recurrence -- 40 Treatment Options for Peritoneal Tumor Recurrence -- XII Environmental Aspects -- 41 Importance of Psycho-Oncology for Tumors of the Peritoneum -- 42 Nursing Aspects of Peritoneal Surface Malignancy -- XIII Guidelines and centres -- 43 Guideline preparation and center development for the treatment of peritoneal tumors in Germany -- 44 Guideline preparation and center development for the treatment of peritoneal tumors in Switzerland -- Service part -- 45 Checklists for the treatment of tumors of the peritoneum. Framework SOP -- Index.
520 $a This book provides surgeons and oncologists with a well-founded and detailed overview of the available treatment options for peritoneal malignancy and differential selection of the appropriate forms of therapy. Systemic chemotherapy options are also considered, as are surgical cytoreduction (CRS) and all forms of intraperitoneal chemotherapy (IPC) especially hyperthermic IPC (HIPEC), and immunotherapy, including specific procedures such as PIPAC. Subsequent chapters address perioperative care, complications and recurrences, as well as psycho-oncological, palliative medical and nursing care. The process of parietal and visceral peritonectomy in the large and small intestine is additionally illustrated by three video clips accessible online. Covering a broad range of aspects, including peritoneal metastasis and intraperitoneal chemotherapy, the book offers a valuable tool for surgeons, oncologists and anesthesiologists alike.
650 0 $a Peritoneum $x Cancer. $3 2157988
650 0 $a Peritoneum $x Tumors. $3 3496220
650 1 4 $a Surgery. $3 707153
650 2 4 $a Oncology. $3 751006
650 2 4 $a Anesthesiology. $3 815920
650 2 4 $a Rehabilitation Medicine. $3 891331
700 1 $a Rau, Beate. $3 3496219
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-62640-2
950 $a Medicine (SpringerNature-11650)